377 related articles for article (PubMed ID: 22332190)
1. Stiff-man syndrome and variants: clinical course, treatments, and outcomes.
McKeon A; Robinson MT; McEvoy KM; Matsumoto JY; Lennon VA; Ahlskog JE; Pittock SJ
Arch Neurol; 2012 Feb; 69(2):230-8. PubMed ID: 22332190
[TBL] [Abstract][Full Text] [Related]
2. Childhood onset of stiff-man syndrome.
Clardy SL; Lennon VA; Dalmau J; Pittock SJ; Jones HR; Renaud DL; Harper CM; Matsumoto JY; McKeon A
JAMA Neurol; 2013 Dec; 70(12):1531-6. PubMed ID: 24100349
[TBL] [Abstract][Full Text] [Related]
3. Stiff man syndrome and related conditions.
Meinck HM; Thompson PD
Mov Disord; 2002 Sep; 17(5):853-66. PubMed ID: 12360534
[TBL] [Abstract][Full Text] [Related]
4. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
[TBL] [Abstract][Full Text] [Related]
5. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
[TBL] [Abstract][Full Text] [Related]
7. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.
Lohmann T; Hawa M; Leslie RD; Lane R; Picard J; Londei M
Lancet; 2000 Jul; 356(9223):31-5. PubMed ID: 10892762
[TBL] [Abstract][Full Text] [Related]
8. High-dose intravenous immune globulin for stiff-person syndrome.
Dalakas MC; Fujii M; Li M; Lutfi B; Kyhos J; McElroy B
N Engl J Med; 2001 Dec; 345(26):1870-6. PubMed ID: 11756577
[TBL] [Abstract][Full Text] [Related]
9. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].
Saiz A; Arias M; Fernández-Barreiro A; Mínguez A; Casamitjana R; Tolosa E; Graus F
Med Clin (Barc); 1998 Mar; 110(10):378-81. PubMed ID: 9567281
[TBL] [Abstract][Full Text] [Related]
11. ['Stiff-person'-syndrome].
Vogels RL; van Orshoven NP; de Koning-Tijssen MA; Wouda EJ
Ned Tijdschr Geneeskd; 2003 Jun; 147(25):1228-32. PubMed ID: 12848059
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyolysis and paraneoplastic stiff-man syndrome with amphiphysin autoimmunity.
Petzold GC; Marcucci M; Butler MH; van Landeghem FK; Einhäupl KM; Solimena M; Valdueza JM; De Camilli P
Ann Neurol; 2004 Feb; 55(2):286-90. PubMed ID: 14755734
[TBL] [Abstract][Full Text] [Related]
13. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer.
Folli F; Solimena M; Cofiell R; Austoni M; Tallini G; Fassetta G; Bates D; Cartlidge N; Bottazzo GF; Piccolo G; De Camilli P
N Engl J Med; 1993 Feb; 328(8):546-51. PubMed ID: 8381208
[TBL] [Abstract][Full Text] [Related]
15. Stiff-leg syndrome: a focal form of stiff-man syndrome.
Saiz A; Graus F; Valldeoriola F; Valls-Solé J; Tolosa E
Ann Neurol; 1998 Mar; 43(3):400-3. PubMed ID: 9506561
[TBL] [Abstract][Full Text] [Related]
16. [Stiff-person syndrome and related autoantibodies].
Tomioka R; Tanaka K
Brain Nerve; 2013 Apr; 65(4):395-400. PubMed ID: 23568987
[TBL] [Abstract][Full Text] [Related]
17. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.
Söhnlein P; Müller M; Syren K; Hartmann U; Böhm BO; Meinck HM; Knip M; Akerblom HK; Richter W
Diabetologia; 2000 Feb; 43(2):210-7. PubMed ID: 10753043
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
19. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.
Carvajal-González A; Leite MI; Waters P; Woodhall M; Coutinho E; Balint B; Lang B; Pettingill P; Carr A; Sheerin UM; Press R; Press R; Lunn MP; Lim M; Maddison P; Meinck HM; Vandenberghe W; Vincent A
Brain; 2014 Aug; 137(Pt 8):2178-92. PubMed ID: 24951641
[TBL] [Abstract][Full Text] [Related]
20. Sudden spasms following gradual lordosis--the stiff-person syndrome.
Wilson RK; Murinson BB
Nat Clin Pract Neurol; 2006 Aug; 2(8):455-9; quiz 460. PubMed ID: 16932604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
